Role of angiotensin II and α-adrenergic receptors during estrogen-induced vasodilation in ewes

L. E. Davis, R. R. Magness, C. R. Rosenfeld

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Estradiol-17β (E2β) produces uterine and systemic vasodilation in nonpregnant ewes without altering mean arterial pressure (MAP). Mechanisms responsible for maintaining MAP and thus uterine blood flow (UBF) may include activation of the renin-angiotensin and/or adrenergic systems. We therefore investigated the effects of systemic blockade of angiotensin II (ANG II) and/or α-adrenergic receptors in nonpregnant, castrated ewes, using saralasin (Sar) and/or phentolamine (Phen) in the presence or absence of intravenous E2β (1.0 μg/kg). In nonestrogenized ewes neither antagonist alone had substantial cardiovascular effects; however, Sar + Phen decreased systemic vascular resistance (SVR) 20 ± 7.4% (SE) and increased heart rate (HR) 50 ± 19% (P < 0.01); MAP and UBF were unaffected. Following E2β treatment SVR fell 17 ± 2.4% (P < 0.01), UBF increased more than fourfold, and MAP was unchanged. Compared with E2β alone, Phen + E2β decreased SVR 42 ± 4.7%, and MAP fell 11 ± 1.8% (P < 0.05) despite 40-50% increases in HR and cardiac output (P < 0.05). Responses to Sar + E2β were similar to E2β alone, except for a fall in MAP, whereas responses to Sar + Phen + E2β resembled those of Phen + E2β. E2β-induced uterine vasodilation was unaltered by Sar and/or Phen. During E2β-induced vasodilation, MAP is maintained by enhanced activation of the α-adrenergic and renin-angiotensin systems; however, uterine vascular responses to E2β are independent of both systems and perfusion pressure.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume263
Issue number5 26-5
StatePublished - 1992

Fingerprint

Angiotensin Receptors
Saralasin
Phentolamine
Vasodilation
Angiotensin II
Adrenergic Receptors
Arterial Pressure
Estrogens
Vascular Resistance
Blood
Angiotensins
Adrenergic Agents
Renin
Heart Rate
Chemical activation
Renin-Angiotensin System
Cardiac Output
Blood Vessels
Estradiol
Perfusion

Keywords

  • blood pressure control
  • cardiac output
  • heart rate
  • uterine blood flow

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology

Cite this

Role of angiotensin II and α-adrenergic receptors during estrogen-induced vasodilation in ewes. / Davis, L. E.; Magness, R. R.; Rosenfeld, C. R.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 263, No. 5 26-5, 1992.

Research output: Contribution to journalArticle

@article{e2a597c426834fb3a0d47033c6f7af17,
title = "Role of angiotensin II and α-adrenergic receptors during estrogen-induced vasodilation in ewes",
abstract = "Estradiol-17β (E2β) produces uterine and systemic vasodilation in nonpregnant ewes without altering mean arterial pressure (MAP). Mechanisms responsible for maintaining MAP and thus uterine blood flow (UBF) may include activation of the renin-angiotensin and/or adrenergic systems. We therefore investigated the effects of systemic blockade of angiotensin II (ANG II) and/or α-adrenergic receptors in nonpregnant, castrated ewes, using saralasin (Sar) and/or phentolamine (Phen) in the presence or absence of intravenous E2β (1.0 μg/kg). In nonestrogenized ewes neither antagonist alone had substantial cardiovascular effects; however, Sar + Phen decreased systemic vascular resistance (SVR) 20 ± 7.4{\%} (SE) and increased heart rate (HR) 50 ± 19{\%} (P < 0.01); MAP and UBF were unaffected. Following E2β treatment SVR fell 17 ± 2.4{\%} (P < 0.01), UBF increased more than fourfold, and MAP was unchanged. Compared with E2β alone, Phen + E2β decreased SVR 42 ± 4.7{\%}, and MAP fell 11 ± 1.8{\%} (P < 0.05) despite 40-50{\%} increases in HR and cardiac output (P < 0.05). Responses to Sar + E2β were similar to E2β alone, except for a fall in MAP, whereas responses to Sar + Phen + E2β resembled those of Phen + E2β. E2β-induced uterine vasodilation was unaltered by Sar and/or Phen. During E2β-induced vasodilation, MAP is maintained by enhanced activation of the α-adrenergic and renin-angiotensin systems; however, uterine vascular responses to E2β are independent of both systems and perfusion pressure.",
keywords = "blood pressure control, cardiac output, heart rate, uterine blood flow",
author = "Davis, {L. E.} and Magness, {R. R.} and Rosenfeld, {C. R.}",
year = "1992",
language = "English (US)",
volume = "263",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 26-5",

}

TY - JOUR

T1 - Role of angiotensin II and α-adrenergic receptors during estrogen-induced vasodilation in ewes

AU - Davis, L. E.

AU - Magness, R. R.

AU - Rosenfeld, C. R.

PY - 1992

Y1 - 1992

N2 - Estradiol-17β (E2β) produces uterine and systemic vasodilation in nonpregnant ewes without altering mean arterial pressure (MAP). Mechanisms responsible for maintaining MAP and thus uterine blood flow (UBF) may include activation of the renin-angiotensin and/or adrenergic systems. We therefore investigated the effects of systemic blockade of angiotensin II (ANG II) and/or α-adrenergic receptors in nonpregnant, castrated ewes, using saralasin (Sar) and/or phentolamine (Phen) in the presence or absence of intravenous E2β (1.0 μg/kg). In nonestrogenized ewes neither antagonist alone had substantial cardiovascular effects; however, Sar + Phen decreased systemic vascular resistance (SVR) 20 ± 7.4% (SE) and increased heart rate (HR) 50 ± 19% (P < 0.01); MAP and UBF were unaffected. Following E2β treatment SVR fell 17 ± 2.4% (P < 0.01), UBF increased more than fourfold, and MAP was unchanged. Compared with E2β alone, Phen + E2β decreased SVR 42 ± 4.7%, and MAP fell 11 ± 1.8% (P < 0.05) despite 40-50% increases in HR and cardiac output (P < 0.05). Responses to Sar + E2β were similar to E2β alone, except for a fall in MAP, whereas responses to Sar + Phen + E2β resembled those of Phen + E2β. E2β-induced uterine vasodilation was unaltered by Sar and/or Phen. During E2β-induced vasodilation, MAP is maintained by enhanced activation of the α-adrenergic and renin-angiotensin systems; however, uterine vascular responses to E2β are independent of both systems and perfusion pressure.

AB - Estradiol-17β (E2β) produces uterine and systemic vasodilation in nonpregnant ewes without altering mean arterial pressure (MAP). Mechanisms responsible for maintaining MAP and thus uterine blood flow (UBF) may include activation of the renin-angiotensin and/or adrenergic systems. We therefore investigated the effects of systemic blockade of angiotensin II (ANG II) and/or α-adrenergic receptors in nonpregnant, castrated ewes, using saralasin (Sar) and/or phentolamine (Phen) in the presence or absence of intravenous E2β (1.0 μg/kg). In nonestrogenized ewes neither antagonist alone had substantial cardiovascular effects; however, Sar + Phen decreased systemic vascular resistance (SVR) 20 ± 7.4% (SE) and increased heart rate (HR) 50 ± 19% (P < 0.01); MAP and UBF were unaffected. Following E2β treatment SVR fell 17 ± 2.4% (P < 0.01), UBF increased more than fourfold, and MAP was unchanged. Compared with E2β alone, Phen + E2β decreased SVR 42 ± 4.7%, and MAP fell 11 ± 1.8% (P < 0.05) despite 40-50% increases in HR and cardiac output (P < 0.05). Responses to Sar + E2β were similar to E2β alone, except for a fall in MAP, whereas responses to Sar + Phen + E2β resembled those of Phen + E2β. E2β-induced uterine vasodilation was unaltered by Sar and/or Phen. During E2β-induced vasodilation, MAP is maintained by enhanced activation of the α-adrenergic and renin-angiotensin systems; however, uterine vascular responses to E2β are independent of both systems and perfusion pressure.

KW - blood pressure control

KW - cardiac output

KW - heart rate

KW - uterine blood flow

UR - http://www.scopus.com/inward/record.url?scp=0026448107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026448107&partnerID=8YFLogxK

M3 - Article

C2 - 1332496

AN - SCOPUS:0026448107

VL - 263

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5 26-5

ER -